目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Distribution Channel
1.2.3. Application
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product and Distribution Channel outlook
2.2.2. Application outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Senolytics & Anti-Aging Pharmaceuticals Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising anti-aging burden
3.2.1.2. Advancements in drug development
3.2.1.3. Growing awareness about anti-aging treatment
3.2.2. Market restraint analysis
3.2.2.1. High cost of development
3.2.2.2. Regulatory challenges for new drug approvals
3.3. Senolytics & Anti-Aging Pharmaceuticals Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
3.3.4. Pipeline Analysis
3.3.4.1. Phase 1
3.3.4.2. Phase 2
3.3.4.3. Phase 2

Chapter 4. Senolytics & Anti-Aging Pharmaceuticals Market: Product Estimates & Trend Analysis
4.1. Global Senolytics & Anti-Aging Pharmaceuticals Market: Product Dashboard
4.2. Global Senolytics & Anti-Aging Pharmaceuticals Market: Product Movement Analysis
4.3. Global Senolytics & Anti-Aging Pharmaceuticals Market by Product, Revenue
4.4. Anti-Aging Pharmaceuticals
4.4.1. Anti-Aging Pharmaceuticals market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Senolytic Agents
4.5.1. Senolytic Agents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Senolytics & Anti-Aging Pharmaceuticals Market: Distribution Channel Estimates & Trend Analysis
5.1. Global Senolytics & Anti-Aging Pharmaceuticals Market: Distribution Channel Dashboard
5.2. Global Senolytics & Anti-Aging Pharmaceuticals Market: Distribution Channel Movement Analysis
5.3. Global Senolytics & Anti-Aging Pharmaceuticals Market by Distribution Channel, Revenue
5.4. Prescription-Based
5.4.1. Prescription-Based monoclonal antibodies market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Over-the-Counter (OTC) / Supplements
5.5.1. Over-the-Counter (OTC) / Supplements market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Clinical Trials / Compassionate Use
5.6.1. Clinical Trials / Compassionate Use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Senolytics & Anti-Aging Pharmaceuticals Market: Application Estimates & Trend Analysis
6.1. Global Senolytics & Anti-Aging Pharmaceuticals Market: Application Dashboard
6.2. Global Senolytics & Anti-Aging Pharmaceuticals Market: Application Movement Analysis
6.3. Global Senolytics & Anti-Aging Pharmaceuticals Market by Application, Revenue
6.4. Consumer Wellness / Longevity Use
6.4.1. Consumer Wellness / Longevity Use market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Clinical Use / Off-label Therapeutics
6.5.1. Clinical Use / Off-label Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Senolytics & Anti-Aging Pharmaceuticals Market: Regional Estimates & Trend Analysis by Product, Application, and Distribution Chnnel
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2024
8.3.4. Unity Biotechnology.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Novartis AG.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. F. Hoffmann-La Roche AG.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Merck & Co., Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Pfizer Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Sanofi
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. AstraZeneca
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Johnson & Johnson Services Inc.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Abbott
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Sun Pharmaceutical Industries Ltd
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Senolytic Therapeutics Inc.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. AgeX Therapeutics
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 3 North America Senolytics & Anti-Aging Pharmaceuticals Market, by Route of, 2018 - 2030 (USD Million)
Table 4 North America Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 5 U.S. Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 6 U.S. Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 7 U.S. Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 8 Canada Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 9 Canada Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 10 Canada Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 11 Mexico Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 12 Mexico Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Mexico Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 14 Europe Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 15 Europe Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Europe Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 17 Germany Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 18 Germany Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Germany Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 20 UK Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 21 UK Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 22 UK Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 23 France Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 24 France Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 25 France Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 26 Italy Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 27 Italy Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 28 Italy Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 29 Spain Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 30 Spain Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 31 Spain Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 32 Asia Pacific Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 35 China Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 36 China Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 37 China Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 38 Japan Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 39 Japan Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Japan Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 41 India Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 42 India Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 43 India Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 44 South Korea Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 45 South Korea Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 46 South Korea Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 47 Latin America Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 48 Latin America Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 49 Latin America Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 50 Brazil Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 51 Brazil Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Brazil Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 53 MEA Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 54 MEA Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 55 MEA Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 56 South Africa Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 57 South Africa Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 58 South Africa Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 62 UAE Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 63 UAE Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 64 UAE Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)
Table 65 Kuwait Senolytics & Anti-Aging Pharmaceuticals Market, by Product, 2018 - 2030 (USD Million)
Table 66 Kuwait Senolytics & Anti-Aging Pharmaceuticals Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 67 Kuwait Senolytics & Anti-Aging Pharmaceuticals Market, by Application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Senolytics & Anti-Aging Pharmaceuticals market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product and Distribution Channel segment snapshot
Fig. 10 Application segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Pharmaceutical market, (USD Billion)
Fig. 13 Market dynamics
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Senolytics & Anti-Aging Pharmaceuticals market: Product outlook and key takeaways
Fig. 17 Senolytics & Anti-Aging Pharmaceuticals market: Product movement analysis
Fig. 18 Anti-Aging Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Senolytic Agents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Senolytics & Anti-Aging Pharmaceuticals market: Distribution Channel outlook and key takeaways
Fig. 21 Senolytics & Anti-Aging Pharmaceuticals market: Distribution Channel movement analysis
Fig. 22 Prescription-Based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Over-the-Counter (OTC) / Supplements market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Clinical Trials / Compassionate Use market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Senolytics & Anti-Aging Pharmaceuticals market: Application outlook and key takeaways
Fig. 26 Senolytics & Anti-Aging Pharmaceuticals market: Application channel movement analysis
Fig. 27 Consumer Wellness / Longevity Use market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Clinical Use / Off-label Therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Senolytics & Anti-Aging Pharmaceuticals market revenue, by region, 2024 & 2030 (USD Million)
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 North America senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 Target disease prevalence
Fig. 35 U.S. senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Key country dynamics
Fig. 37 Target disease prevalence
Fig. 38 Canada senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Mexico senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 Target disease prevalence
Fig. 42 Europe senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 Target disease prevalence
Fig. 45 UK senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Target disease prevalence
Fig. 48 Germany senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Target disease prevalence
Fig. 51 France senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Target disease prevalence
Fig. 54 Spain senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Target disease prevalence
Fig. 57 Italy senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Target disease prevalence
Fig. 60 Denmark senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Target disease prevalence
Fig. 63 Sweden senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Target disease prevalence
Fig. 66 Norway senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Rest of Europe senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Asia Pacific senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Target disease prevalence
Fig. 71 Japan senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Target disease prevalence
Fig. 74 China senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Target disease prevalence
Fig. 77 India senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Target disease prevalence
Fig. 80 Australia senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Thailand senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 South Korea senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Rest of Asia Pacific senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Latin America senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Target disease prevalence
Fig. 89 Brazil senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Target disease prevalence
Fig. 92 Argentina senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Rest of Latin America senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 MEA senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Target disease prevalence
Fig. 97 South Africa senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Target disease prevalence
Fig. 100 Saudi Arabia senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Target disease prevalence
Fig. 103 UAE senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Key country dynamics
Fig. 105 Target disease prevalence
Fig. 106 Kuwait senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Rest of MEA senolytics & anti-aging pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)